Side effects during recombinant human erythropoietin therapy in 2,000 ESRD patients.
Samtleben
W
W
Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, FRG.
Ehmer
B
B
Lutz-Knochenhauer
I
I
Hagmann
C
C
Scigalla
P
P
Gurland
H J
HJ
D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D006435:Renal Dialysis; D015996:Survival Rate
D011994:Recombinant Proteins; D004921:Erythropoietin